Patents by Inventor Reid von Borstel

Reid von Borstel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and methods for the detection of methotrexate
    Patent number: 11054430
    Abstract: The disclosure relates generally to methods of detecting and quantifying methotrexate (MTX) in a sample. The methods disclosed herein decrease cross-reactivity and improve sensitivity of the detection.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: July 6, 2021
    Assignee: Defined Diagnostics, LLC
    Inventors: Reid von Borstel, Paul Hu, Xiaofen Huang, Jeffrey Allan Miller
  • COMPOUNDS AND METHODS FOR THE DETECTION OF METHOTREXATE
    Publication number: 20180328952
    Abstract: The disclosure relates generally to methods of detecting and quantifying methotrexate (MTX) in a sample. The methods disclosed herein decrease cross-reactivity and improve sensitivity of the detection.
    Type: Application
    Filed: July 7, 2016
    Publication date: November 15, 2018
    Inventors: Reid von BORSTEL, Paul HU, Xiaofen HUANG, Jeffrey Allan Miller
  • Device and method for simulating chemosensation of smoking
    Patent number: 10098379
    Abstract: A device for simulating a chemosenzation of smoking includes an outer layer, a porous medium and a chemesthetic agent. The porous medium is disposed within the outer layer. The chemesthetic agent is disposed within the porous medium and activates a TRP channel.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: October 16, 2018
    Assignee: Sentiens, LLC
    Inventors: Reid von Borstel, Dennis Tan, John Siverling, Inna S. Timokhina
  • AGENTS AND METHODS FOR MODULATING THE SENSORY IMPACT OF TOBACCO OR HERBAL SMOKE
    Publication number: 20180084827
    Abstract: A combustible device includes a wrapper, tobacco disposed in the wrapper, and an agent that activates a TRPA1 channel disposed in the wrapper.
    Type: Application
    Filed: September 22, 2017
    Publication date: March 29, 2018
    Inventors: Reid von Borstel, Dennis Tan, John Siverling
  • COMPOSITIONS AND THEIR USE FOR SMOKING CESSATION AND OTHER TREATMENTS
    Publication number: 20150038576
    Abstract: A composition includes a liquid. The liquid aerosolizes for delivery to a user by an airway. The liquid includes an agent that activates a TRPV3 channel. The agent includes a terpenoid compound.
    Type: Application
    Filed: August 1, 2014
    Publication date: February 5, 2015
    Applicant: SENTIENS, LLC
    Inventors: Inna S. Timokhina, Reid von Borstel, Dennis Tan, John Siverling
  • DEVICE AND METHOD FOR SIMULATING CHEMOSENSATION OF SMOKING
    Publication number: 20140102464
    Abstract: A device for simulating a chemosensation of smoking includes an outer layer, a porous medium and a chemesthetic agent. The porous medium is disposed within the outer layer. The chemesthetic agent is disposed within the porous medium and activates a TRP channel.
    Type: Application
    Filed: December 18, 2013
    Publication date: April 17, 2014
    Applicant: Sentiens, LLC
    Inventors: Reid von Borstel, Dennis Tan, John Siverling, Inna S. Timokhina
  • Device and method for simulating chemosensation of smoking
    Patent number: 8646461
    Abstract: A device for simulating a chemosensation of smoking includes an outer layer, a porous medium and a chemesthetic agent. The porous medium is disposed within the outer layer. The chemesthetic agent is disposed within the porous medium and activates a TRP channel.
    Type: Grant
    Filed: December 11, 2012
    Date of Patent: February 11, 2014
    Assignee: Sentiens, LLC
    Inventors: Reid von Borstel, Dennis Tan, John Siverling, Inna S. Timokhina
  • Treatment of neoplasms with viruses
    Publication number: 20080057037
    Abstract: The subject invention relates to viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response, and their use in treating neoplastic disease including cancer and large tumors. RNA and DNA viruses are useful in this regard. The invention also relates to methods for the selection, design, purification and use of such viruses for cancer therapy.
    Type: Application
    Filed: January 29, 2007
    Publication date: March 6, 2008
    Applicant: Pro-Virus, Inc.
    Inventors: Michael Roberts, Robert Lorence, William Groene, Harvey Rabin, Reid von Borstel
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20080027229
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: August 24, 2007
    Publication date: January 31, 2008
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20080021109
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: August 24, 2007
    Publication date: January 24, 2008
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20080015254
    Abstract: Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed.
    Type: Application
    Filed: August 20, 2007
    Publication date: January 17, 2008
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Kirvin Hodge, Shalini Sharma, Albert Lee, Reid von Borstel
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20080015209
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: August 20, 2007
    Publication date: January 17, 2008
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • Compounds for the Treatment of Metabolic Disorders
    Publication number: 20070282003
    Abstract: Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed.
    Type: Application
    Filed: August 16, 2004
    Publication date: December 6, 2007
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070265322
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: November 15, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070265323
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: November 15, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070249719
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 25, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070249696
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 25, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070244171
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 18, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070244172
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 18, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070244141
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 18, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe